1Bergamaschini L,Canziani S,Bottasso B,et al.Alzheimer's beta-amyloid peptides can activate the early components of complement classical pathway in a C1q-independent manner[J].Clin Exp Immunol,1999,115(3):526-533.
3Terreni L,De Simoni MG.Role of the brain in interleukin-6 modulation[J].Neuroimmunomodulation,1998,5(3-4):214-219.
4Solomon Beka,Frenker Dan.Vaccination for the prevention and treatment of Alzheimer's disease[J].Drugs Today,2000,36(9):655-663.
5DeWitt DA,Perry G,Cohen M,et al.Astrocytes regulate microglial phagocytosis of senile plaque cores of Alzheimer's disease[J].Exp Neurol,1998,149(2):329-340.
6Rogers J,Lue LF.Microglial chemotaxis,activation,and phagocytosis of amyloid beta-peptide as linked phenomena in Alzheimer's disease[J].Neurochem Int,2001,39(5-6):333-340.
7Kalaria RN.Microglia and Alzheimer's disease[J].Curr Opin Hematol,1999,6(1):15-24.
8Saas P,Boucraut J,Quiquerez AL,et al.CD95 (Fas/Apo-1) as a receptor governing astrocyte apoptotic or inflammatory responses: a key role in brain inflammation?[J].J Immunol,1999,162(4):2326-2333.
9Strohmeyer R,Shen Y,Rogers J.Detection of complement alternative pathway mRNA and proteins in the Alzheimer's disease brain[J].Hum Mol Genet,2000,9(15):2281-2279.
10Webster S,Bonnell B,Rogers J.Charge-based binding of complement component C1q to the Alzheimer amyloid beta-peptide[J].Am J Pathol,1997,150(5):1531-1536.
9Archer HA,McFarlane F,Frost C,et al,Symptoms of Memory loss as Predietors of Cognitive Impairment?; The Use andReliability of Memory Ratings in aclinic Population[J].Alzheimer DisAssoc Disord,2007,21:101-106
